Infrequent alterations of the p16(INK4A) gene in liver cancer

International Journal of Cancer

Volumn 67, Issue 2, 1996, Pages 176-180

  Kita, Ryuichi ^a   Nishida, Naoshi ^a,c   Fukuda, Yoshihiro ^a   Azechi, Hidemasa ^a   Matsuoka, Yoko ^a   Komeda, Toshiki ^a   Sando, Takehiro ^a   Nakao, Kazuwa ^a   Ishizaki, Kanji ^b  

^a KYOTO UNIVERSITY   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

^c Department of Surgery   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CARRIER PROTEIN; CDK4 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE 4; ONCOPROTEIN; PROTEIN P16INK4A;

AMINO ACID SUBSTITUTION; ARTICLE; CELL CYCLE G0 PHASE; CHROMOSOME ABERRATION; ENZYME INHIBITION; GENE DELETION; GENE MUTATION; GENETIC HETEROGENEITY; HUMAN; HUMAN TISSUE; LIVER CANCER; LIVER CARCINOGENESIS; MISSENSE MUTATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; CELL CULTURE; EXON; GENETICS; HOMOZYGOTE; LIVER CELL CARCINOMA; LIVER TUMOR; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION;

BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CARRIER PROTEINS; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASES; EXONS; GENE DELETION; HOMOZYGOTE; HUMANS; LIVER NEOPLASMS; MOLECULAR SEQUENCE DATA; MUTATION; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS; TUMOR CELLS, CULTURED;

EID: 0029665012     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960717)67:2<176::AID-IJC4>3.0.CO;2-Q     Document Type: Article

References (25)

1. CAIRNS, P., TOKINO, K., EBY, Y. and SIDRANSKY, D., Localization of tumor-suppressor loci on chromosome 9 in primary human renal-cell carcinomas. Cancer Res., 55, 224-227 (1995).
2. CALDAS, C., HAHN, S.A., DA COSTA, L.T., REDSTON, M.S., SCHUTTE, M., SEYMOUR, A.B., WEINSTEIN, C.L., HRUBAN, R.H., YEO, C.J. and KERN, S.E., Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nature Genetics, 8, 27-32 (1994).
3. CHENG, J.Q., JHANWAR, S.C., KLEIN, W.M., BELL, D.W., LEE, W.-C., ALTOMARE, D.A., NOBORI, T., OLOPADE, O.I., BUCHLER, A.J. and TESTA, J.R., p16 alterations and deletion mapping of 9p21-22 in malignant mesothelioma. Cancer Res., 54, 5547-5551 (1994).
4. EDMONDSON, H.A. and STEINER, P.E., Primary carcinoma of the liver. A study of 100 cases among 48,900 necropsies. Cancer, 7, 462-503 (1954).
5. FOUNTAIN, J.W., KARAYIORGOU, M., ERNSTOFF, M.S., KIRKWOOD, J.M., VLOVK, D.R., TITUS-ERNSTOFF, L., BOUCHARD, B., VIJAYASARADHI, S., HOUGHTON, A.N., LAHTI, J., KIDD, V.J., HAUSMAN, D.E. and DRACOPOLI, N.C., Homozygous deletions within human chromosome band 9p21 in melanoma. Proc. nat. Acad. Sci. (Wash.), 89, 10557-10561 (1992).
6. HERMAN, J.G., MERLO, A., MAO, L., LAPIDUS, R.G., ISSA, J.-P.J., DAVIDSON, N.E., SIDRANSKY, D. and BAYLIN, S.B., Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res., 55, 4525-4530 (1995).
7. KAMB, A., GRIUS, N.A., WEAVER-FELDHAUS, J., LIU, Q., HARSHMAN, K., TAVTIGIAN, S.V., STOCKERT, E., DAY III, R.S., JOHNSON, B.E. and SKOLNICK, M.H., A cell-cycle regulator potentially involved in genesis of many tumor types. Science, 264, 436-440 (1994).
8. KHATIB, Z.A., MATSUSHIME, H., VALENTINE, M., SHAPIRO, D.N., SHERR, C.J. and LOOK, A.T., Co-amplification of the CDK4 gene with MDM2 and GLI in human sarcomas. Cancer Res., 53, 5535-5541 (1993).
9. KINOSHITA, H., YAMADA, H., OGAWA, O., KAKEHI, Y., OSAKA, M., NAKAMURA, E., MISHINA, M., HABUCHI, T., TAKAHASHI, R., SUGIYAMA, T. and YOSHIDA, O., Contribution of chromosome 9p21-22 deletion to the progression of human renal-cell carcinoma. Jap. J. Cancer Res., 86, 795-799 (1995).
10. KWIATKOWSKl, D.J. and DIAZ, M.O., Dinucleotide repeat polymorphism at the IFNA locus (9p22). Hum. Mol. Genet., 1, 658 (1993).
11. LIVER CANCER STUDY GROUP OF JAPAN, The general rules for the clinical and pathological study of primary liver cancer (3rd ed.), pp. 22-23, Kanehara Press, Tokyo (1992).
12. MERLO, A., HERMAN, J.G., MAO, L., LEE, D.J., GABRIELSON, E., BURGER, P.C., BAYLIN, S.B. and SIDRANSKY, D., 5′ CpG island methylation is associated with transcriptional silencing of the tumoursuppressor p16/CDKN2/MTS1 in human cancers. Nature Med., 1, 686-692 (1995).
13. MORI, T., MIURA, K., AOKI, T., NISHIHARA, T., MORI, S. and NAKANURA, Y., Frequent somatic mutation of the MTS1/CDK4I (multiple tumor-suppressor/cyclin-dependent kinase-4 inhibitor) gene in esophageal squamous-cell carcinoma. Cancer Res., 54, 3396-3397 (1994).
14. MOTOKURA, T., BLOOM, T., KIM, H.G., JUPPNER, H., RUDERMAN, J.V., KRONENBERG, H.M. and ARNOLD, A.A., A novel cyclin encoded by a bell-linked candidate oncogene. Nature (Lond.), 350, 512-515 (1991).
15. NISHIDA, N., FUKUDA, Y., KOKURYU, H., SADAMOTO, T., ISOWA, G., HONDA, K., YAMAOKA, Y., IKENAGA, M., IMURA, H. and ISHIZAKI, K., Accumulation of allelic loss on arms of chromosomes 13q, 16q and 17p in the advanced stages of human hepatocellular carcinoma. Int. J. Cancer, 51, 862-868 (1992).
16. NISHIDA, N., FUKUDA, Y., KOKURYU, H., TOGUCHIDA, J., YANDELL, D.W., IKENAGA, M., IMURA, H. and ISHIZAKI, K., Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma. Cancer Res., 53, 368-372 (1993).
17. NISHIDA, N., FUKUDA, Y., KOMEDA, T., KITA, R., SANDO, T., FURUKAWA, M., AMENOMORI, M., SHIBAGAKI, I., NAKAO, K., IKENAGA, M. and ISHIZAKI, K., Amplification and over-expression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res., 54, 3107-3110 (1994).
18. NOBORI, T., MIURA, K., WU, D.J., LOIS, A., TAKABAYASHI, K. and CARSON, D.A., Deletion of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (Lond.), 368, 753-756 (1994).
19. INK4 in human cancer. Proc. nat. Acad. Sci. (Wash.), 91, 11045-11049 (1994).
20. OLOPADE, O.I., JENKINS, R.B., RANSOM, D.T., MALIK, K., POMYKALA, H., NOBORI, T., COWAN, J.M., ROWLEY, J.D. and DIAZ, M.O., Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas. Cancer Res., 52, 2523-2529 (1992).
21. SAMBROOK, J., FRITSCH, E.F. and MANIATIS, T., Molecular cloning, pp. 382-389. Cold Spring Harbor Laboratory, New York (1982).
22. SCHMIDT, E.E., ICHIMURA, K., REIFENBERGER, G. and COLLINS, V.P., CDKN2(p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res., 54, 6321-6324 (1994).
23. SERRANO, M., HANNON, G.J. and BEACH, D., A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond.), 366, 704-707 (1993).
24. INK4a tumor-suppressor protein. Cancer Res., 55, 2503-2506 (1995).
25. Ink4B/MT52 genes in biliary-tract cancers. Cancer Res., 55, 2756-2760 (1995).